At GlowDx we create Access by combining novel molecular technology with innovative delivery models to ensure our patients always get the answers they need.
Our focus is to use innovation to democratise access to diagnostics globally, ultimately:
Improving Clinical Outcomes
Reducing Economic Burden
Improving Quality of Life
PEOPLE. INNOVATING. TOGETHER.
Blaine Doyle, CEO
Rodrigo Cervantes, VP Commercial
To Be Announced , CSO